NONMEM Users Network Archive

Hosted by Cognigen

2020 Virtual Training Course on PKPD of Protein Therapeutics, December 4-6

From: Meibohm, Bernd <bmeibohm>
Date: Thu, 22 Oct 2020 14:41:53 +0000

Dear Colleagues,

The 2020 Virtual Introductory Training Course on

'Pharmacokinetics and Pharmacodynamics of Protein Therapeutics - Principles=
 & Pharmacometric Approaches'

will be held on December 4-6, 2020.

The 3-day course continues on the successful concept used in previous year =
offerings. It will introduce participants to basic principles in the pharma=
cokinetic and pharmacodynamic evaluation of novel therapeutic proteins and =
will provide PK and PK/PD modeling and simulation examples relevant to ther=
apeutic proteins. Topics include target-mediated drug disposition, interspe=
cies scaling, first-in human dose selection, model-informed drug developmen=
t, pediatric pharmacology, drug-drug interactions, and immunogenicity. The =
target audience comprises pharmaceutical scientists from industry, academia=
 and regulatory agencies with basic knowledge in PK and PKPD that had only =
limited exposure to the challenges associated with developing therapeutic p=
roteins and that would like to receive a comprehensive overview or refreshe=
r on the PK and PKPD of this class of compounds.

Although the course includes some hands-on exercises, participants do NOT n=
eed to have prior experience with any particular PKPD analysis software.

For more detailed information on the preliminary course program and timing,=
 as well as on the registration process, please visit<>

We hope you will join us in December!

The Course Directors
Bernd Meibohm & Johan Gabrielsson

Bernd Meibohm, PhD, FCP, FAAPS
Associate Dean for Research & Graduate Programs
Professor of Pharmaceutical Sciences
The University of Tennessee Health Science Center
College of Pharmacy
Pharmacy Building, Suite 435
881 Madison Avenue
Memphis, TN 38163, USA
t: +1.901.448.1206
f: +1.901.448.6940

Received on Thu Oct 22 2020 - 10:41:53 EDT

The NONMEM Users Network is maintained by ICON plc. Requests to subscribe to the network should be sent to:

Once subscribed, you may contribute to the discussion by emailing: